Impact of CMV-Specific Immune Reconstitution at the End of Letermovir Prophylaxis on the Development of Late Cytomegalovirus Infection in Hematopoietic Stem Cell Transplant Recipients (INMUNOEND)
N/A
Cytomegalovirus (CMV) infection is a common complication in patients underg...
A Randomized Controlled Trial of Prophylactic Rituximab to Reduce Clinically Significant EBV DNAemia After Allogeneic Hematopoietic Stem Cell Transplantation
NA
This is a single-center, prospective, randomized, open-label clinical trial...
Status
Not Yet Recruiting
Location
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
Efficacy and Safety of Leymovir Versus Valganciclovir in Prevention of Cytomegalovirus Infection and Cytomegalovirus Disease in Chinese Kidney Transplant Recipients
PHASE4
the existing anti-CMV drugs mainly include valganciclovir, ganciclovir and ...
Status
Recruiting
Location
The First Affiliated Hospital of Xi 'an Jiaotong University